1.590USD0.00%Mkt Cap: —P/E: —1d ago
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, …
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value181.93M $
Revenue (TTM)77.68M $
Gross Profit18.85M $
Net Income (TTM)-30.72M $
Revenue/Share0.8570 USD
Last Price1.590 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees146
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINUS1920051067
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-9.55
EV/Revenue2.34
P/S—
P/B4.18
EPS (TTM)-0.32
EPS (Forward)—
52W Range
1.49553% of range1.675
52W High1.675 USD
52W Low1.495 USD
Profitability
Gross Margin24.27%
Oper. Margin-75.29%
EBITDA Margin-24.52%
Profit Margin-39.55%
ROE-69.36%
ROA-11.74%
Growth
Revenue Growth-2.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.40M $
CapEx (TTM)—
FCF Margin2.74%
FCF Yield—
Net Debt17.67M $
Net Debt/EBITDA-0.93
Balance Sheet
Debt/Equity220.24
Current Ratio3.06
Quick Ratio2.83
Book Value/Sh0.3610 USD
Cash/Share0.5020 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.54.02M
Float82.35M
Insiders6.15%
Institutions70.43%
Technical
SMA 503.100 (-48.7%)
SMA 2002.507 (-36.6%)
Beta2.50
S&P 52W Chg20.80%
Avg Vol (30d)16.70K
Avg Vol (10d)28.38K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—